Jaffee EM - Search Results

1

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs.

Christmas BJ, Rafie CI, Hopkins AC, Scott BA, Ma HS, Cruz KA, Woolman S, Armstrong TD, Connolly RM, Azad NA, Jaffee EM, Roussos Torres ET. Christmas BJ, et al. Among authors: jaffee em. Cancer Immunol Res. 2018 Dec;6(12):1561-1577. doi: 10.1158/2326-6066.CIR-18-0070. Epub 2018 Oct 19. Cancer Immunol Res. 2018. PMID: 30341213 Free PMC article.

2

Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design.

Golumbek PT, Azhari R, Jaffee EM, Levitsky HI, Lazenby A, Leong K, Pardoll DM. Golumbek PT, et al. Among authors: jaffee em. Cancer Res. 1993 Dec 15;53(24):5841-4. Cancer Res. 1993. PMID: 8261390

3

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.

Simons JW, Jaffee EM, Weber CE, Levitsky HI, Nelson WG, Carducci MA, Lazenby AJ, Cohen LK, Finn CC, Clift SM, Hauda KM, Beck LA, Leiferman KM, Owens AH Jr, Piantadosi S, Dranoff G, Mulligan RC, Pardoll DM, Marshall FF. Simons JW, et al. Among authors: jaffee em. Cancer Res. 1997 Apr 15;57(8):1537-46. Cancer Res. 1997. PMID: 9108457 Free PMC article. Clinical Trial.

4

HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.

Reilly RT, Gottlieb MB, Ercolini AM, Machiels JP, Kane CE, Okoye FI, Muller WJ, Dixon KH, Jaffee EM. Reilly RT, et al. Among authors: jaffee em. Cancer Res. 2000 Jul 1;60(13):3569-76. Cancer Res. 2000. PMID: 10910070

5

The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.

Reilly RT, Machiels JP, Emens LA, Ercolini AM, Okoye FI, Lei RY, Weintraub D, Jaffee EM. Reilly RT, et al. Among authors: jaffee em. Cancer Res. 2001 Feb 1;61(3):880-3. Cancer Res. 2001. PMID: 11221874

6

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

Machiels JP, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM. Machiels JP, et al. Among authors: jaffee em. Cancer Res. 2001 May 1;61(9):3689-97. Cancer Res. 2001. PMID: 11325840

7

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Argani P, et al. Among authors: jaffee em. Cancer Res. 2001 Jun 1;61(11):4320-4. Cancer Res. 2001. PMID: 11389052

8

A white paper: the product of a pancreas cancer think tank.

Kern S, Hruban R, Hollingsworth MA, Brand R, Adrian TE, Jaffee E, Tempero MA. Kern S, et al. Cancer Res. 2001 Jun 15;61(12):4923-32. Cancer Res. 2001. PMID: 11406572 No abstract available.

9

Pancreatic cancer.

Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, Kern SE, Iacobuzio-Donahue CA, Maitra A, Goggins M, Canto MI, Abrams RA, Laheru D, Jaffee EM, Hidalgo M, Yeo CJ. Yeo TP, et al. Among authors: jaffee em. Curr Probl Cancer. 2002 Jul-Aug;26(4):176-275. doi: 10.1067/mcn.2002.129579. Curr Probl Cancer. 2002. PMID: 12399802 Review. No abstract available.

10

Cytokine modified tumor vaccines.

Armstrong TD, Jaffee EM. Armstrong TD, et al. Among authors: jaffee em. Surg Oncol Clin N Am. 2002 Jul;11(3):681-96. doi: 10.1016/s1055-3207(02)00020-0. Surg Oncol Clin N Am. 2002. PMID: 12487062 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters